This trial will be a large-scale, pragmatic, cluster-randomized clinical trial to evaluate the effect of a customized, multifaceted, health system-level quality-improvement (QI) program compared with usual care on heart failure (HF) outcomes and HF quality-of-care metrics.
Outcomes will be assessed in the year following discharge for participants hospitalized with acute HF and history of reduced left ventricular ejection fraction. All participants in the trial will be consented as part of the CONNECT-HF registry on clinical outcomes, medication use, and participant-centered outcomes, including quality-of-life (QOL) assessments, at 6 weeks and 3, 6, and 12 months after discharge, for longitudinal follow-up. Follow-up will occur via a centralized telephone interview by trained personnel via the DCRI Call Center.
A key substudy will assess a participant-engagement strategy (digital) of a mobile application utilizing behavioral tools to reinforce health behaviors, including self-monitoring/self-management and medication adherence.
View study details on ClinicalTrials.gov
August 31, 2018